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Rat HDL, is known to stimulate bile acid synthesis in rat hepatocyte monolayers. The intracellular fate of the cholesterol 
derived from the HDL, was studied using the inhibitor of cholesterol esterification, Sandoz compound 58-035. Rat HDL, 
added to rat hepatocyte monolayers caused a stimulation of cholesterol esterification of 32%. This stimulation could be 
inhibited by 58-035. A small significant increase in bile acid synthesis was also observed in cells in the presence of HDL,, 
confirming our earlier observations. 58-035 prevented this increase. These observations imply that cholesterol entering 
the cell from HDL, is first esterified and can only enter the substrate pool for bile acid synthesis after subsequent intracel- 
lular hydrolysis. 
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1. INTRODUCTION 
Lipoproteins are taken up by cells by a variety of 
mechanisms. Of these the best characterised is 
receptor-mediated endocytosis by the LDL 
pathway [I]. In some tissues non-receptor 
mediated uptake also contributes, and mechanisms 
in which the apoprotein of HDL is taken up at a 
slower rate than its lipid core have also been 
described [2]. In all these cases some of the 
metabolic consequences of uptake of cholesterol 
are known but it is not clear whether cholesterol 
entering a cell by one of these routes is constrained 
to a particular cellular pathway or whether it can 
immediately equilibrate with the cellular 
metabolically active pool [3,4]. In some tissues, 
such as the bovine adrenal cortex, it has been 
possible to demonstrate the route followed by 
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cholesterol derived from LDL within the cell under 
different metabolic conditions [5,6]. In other 
tissues, such as the liver, there are indications that 
there may be compartmentation of cholesterol 
metabolism [3,4] but there has been no direct 
evidence of this. 
Free cholesterol derived from lipoproteins in the 
liver may have a number of fates. This free 
cholesterol may be secreted into the plasma as a 
component of lipoproteins or, with phospholipid 
and bile acids, into bile. Alternatively it may be us- 
ed as a substrate for bile acid synthesis or be 
esterified by the enzyme acyl-CoA : cholesterol 
acyltransferase (ACAT) [4]. We demonstrated a 
few years ago that a rat lipoprotein fraction, HDL2 
can stimulate the production of bile acids in 
monolayers of rat hepatocytes [7]. Here we show 
that this stimulation can be completely blocked by 
the inhibition of cholesterol esterification in the 
cells by the Sandoz compound 58-035. 
2. MATERIALS AND METHODS 
Rat hepatocyte monolayers were prepared by collagenase per- 
fusion of livers obtained from rats that had been maintained on 
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a diet containing 4% cholestyramine to induce bile acid syn- 
thesis. The culture conditions and the measurement of bile acids 
by radioimmunoassay were carried out as described [8]. The 
ACAT inhibitor, Sandoz compound 58-035, provided by Dr J. 
Heider (Sandoz Research Institute, E. Hanover, NJ), was add- 
ed to cell monolayers dissolved in dimethyl sulphoxide (200 pg 
per 2 ml dish in 20 ~1 dimethyl sulphoxide [9]), and cholesterol 
esterification was measured by determining the incorporation 
of [3H]oleic acid into cholesteryl esters [9]. 
Hepatocyte monolayers were prepared independently from 4 
rats. The cells were pretreated with 58-035 or control solvent 
(dimethyl sulphoxide) as described [9]. Mevinolin (obtained 
from Mr A. Alberts, Merck Sharp & Dohme, Rahway, NJ) was 
added (5 PM) to remove the effect of endogenous cholesterol 
synthesis, making the cells more dependent on added lipopro- 
tein. Incubations were carried out for 5 h and bile acids 
estimated in both cells and medium as described in [7]. In some 
of the incubations [‘Hloleic acid was added to estimate 
cholesterol esterification during the final 2 h of incubation [9]. 
HDLz was added to incubations at a concentration of 5OOpg 
per dish, about that corresponding to the plasma concentration 
in rats [7,10]. The lipoprotein fraction was prepared by stan- 
dard centrifugation techniques from rat plasma [11], the frac- 
tion of density 1.085-1.210 being used for the experiments. 
This fraction contained 251 #g protein, 160 pg cholesteryl ester 
and 20 cg free cholesterol in 100 ~1 of the preparation that was 
added to cells. The composition of this fraction is close to that 
reported in [12]. Analysis of this fraction by SDS-gel elec- 
trophoresis showed that apo-A-I was the main apolipoprotein 
present. There were also significant amounts of apo-E and apo- 
A-IV and trace amounts of apo-C-II and apo-D. No apo-B was 
present. 
3. RESULTS AND DISCUSSION 
The addition of HDL2 to the cells in culture 
caused an increase in the synthesis of cholesteryl 
ester of 32% (table 1). Esterification could be in- 
hibited by the addition of 58-035, as we had 
observed previously [9]. This increase, which is 
significant @ < O.Ol), provides a scale over which 
the changes due to HDLz can be compared. The 
data in table 1 suggest hat the cholesterol present 
in the HDL2 was able to enter the cell and increase 
the supply of substrate to the pool for esterifica- 
tion, which is probably not saturated under normal 
conditions [4]. In other experiments we have 
shown that HDLz labelled with [14C]cholesterol in
either the unesterified or esterified form can enter 
rat hepatocytes in monolayer culture and provide 
substrate for bile acid synthesis (Ford, R.P., un- 
published). In related work in vivo and in the per- 
fused liver Stone et al. [13] have shown that 
cholesteryl ester-rich rat HDL can stimulate 
hepatic ACAT activity by 45%, which is a com- 
parable increase to that found in our experiments 
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Table 1 
Esterification of t3H]oleate by rat hepatocyte monolayers in the 
presence of 58-035 and rat HDLr 
Additions pmol cholesteryl ester formed 
1. Control (5 pM mevinolin) 237 * 13 
2. 1 + 58-035 52k 6 
3. 1 + HDLz 312 + 18 
4. 2 + 58-035 69+ 10 
Cells (4 independent preparations) were incubated in the 
presence of additions for 5 h. During the last 2 h of this period 
potassium [-)H]oleate was added. At the end of the incubations 
the lipids were extracted and the radioactivity in the cholesteryl 
esters determined after separation on silica Bond-Elut columns. 
Data are the means + SD of 4 independent preparations assayed 
in duplicate culture dishes 
in hepatocytes. However, unlike the experiments in 
cell culture [7, lo], no increase in bile salt synthesis 
was observed. 
We have shown previously that 58-035 does not 
inhibit cholesterol 7a-hydroxylase [7] or HMG- 
CoA reductase [5]. Other enzymes of cholesterol 
metabolism in certain cell types (e.g. cholesteryl 
ester hydrolase in bovine adrenal cortical cells) are 
also unaffected by 58-035 [5]. In the present ex- 
periments cholesterol synthesis in the cultured 
hepatocytes was inhibited by mevinolin, so any in- 
direct effects of 58-035 on HMG-CoA reductase 
activity over the 5 h incubation period would not 
be of significance. The basal rate of synthesis and 
secretion of bile acids by the cells in 5 h was 2.47 
+ 0.46 nmol per 2 x lo6 cells. The changes caused 
by the addition of HDLz and 58-035 in each of the 
4 animals studied (and the corresponding mean 
values) are shown in fig. 1. Comparison of the ab- 
solute values from which these differences were 
calculated by the two-tailed paired t-test showed 
that the changes were significant with p < 0.05. 
The data in fig.1 show that, in addition to caus- 
ing an increase in cholesterol esterification, the 
added HDL2 caused a small but significant 
stimulation of bile acid synthesis. This observation 
was reported previously from our group [7] and 
has been confirmed under slightly different ex- 
perimental conditions [lo]. Thus cholesterol de- 
rived from the added lipoprotein was available as 
substrate for both ACAT and cholesterol 7a- 
hydroxylase, the initial step in bile acid synthesis 
141. 
Free cholesterol is required as the substrate for 
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Fig.1. Change in bile acid synthesis by rat hepatocyte 
monolayers in the presence of mevinolin, 58-035 and rat HDL2. 
Rat hepatocytes were incubated with the additions shown under 
the conditions described in section 2. The data shown are the 
changes in bile acid synthesis compared with the control value 
for preparations of cells from each of 4 rats. Error bars show 
the standard deviation of triplicate determinations of the 
secreted bile acids by radioimmunoassay [8]. 
cholesterol 7cu-hydroxylase [ 141. Therefore 
cholesterol entering the cell as cholesteryl ester 
must be hydrolysed at some stage before it enters 
the substrate pool for synthesis of bile acids. Free 
cholesterol entering the cell could in principle 
penetrate either directly to the substrate pool for 
bile acid synthesis or be esterified by ACAT. If the 
route followed in the cell by either free cholesterol 
or cholesteryl ester from the lipoprotein leads com- 
pulsorily through esterification by ACAT, this 
should be detectable by inhibition of this activity 
by 58-035. Fig. 1 shows that the increase in bile acid 
synthesis due to the addition of HDLz is complete- 
ly blocked by the inhibition of ACAT (table 1). 
Under the present conditions, therefore, the im- 
mediate fate of the cholesterol taken up by the cells 
from HDL2 must be esterification. 
This observation is in contrast to our recent ex- 
periments in which the fate of excess cholesterol 
newly synthesised from endogenous mevalonate 
was studied [9]. Here cholesterol esterification was 
stimulated about 2-fold by the addition of 
mevalonic acid and bile acid synthesis was also 
slightly stimulated. However, in this case 58-035 
caused a significant increase in the secretion of bile 
acids, implying that excess cholesterol could be 
diverted to bile acid synthesis from the ACAT 
substrate pool. 
It is clearly important in experiments with 
hepatocyte monolayers to attempt to correlate 
them with the in vivo situation. In the present ex- 
periments HDL2, a specific homologous lipopro- 
tein fraction which carries a substantial amount of 
cholesterol in the rat, can deliver cholesterol to the 
hepatocyte. This cholesterol follows a defined in- 
tracellular pathway, through ACAT to form the 
ester, followed by hydrolysis before it can become 
a substrate for bile acid synthesis. The limiting step 
in this system is probably the uptake of the 
lipoprotein by the cultured cells. This experimental 
design represents a close approximation in a 
hepatocyte monolayer culture to the situation in 
vivo. In our earlier experiments [9] the intracellular 
transport and regulatory mechanisms were prob- 
ably saturated by the excess cholesterol synthesised 
from the added mevalonate. Uptake mechanisms 
were by-passed. 
It is possible in cell culture experiments to devise 
conditions that will channel cholesterol from dif- 
ferent sources in any desired way. Such control can 
be carried out with bovine adrenal cortical cells, 
which can use cholesterol from any of several 
sources as a substrate for synthesis of cortisol 
[4,6]. Studies such as those reported here show 
what pathways are possible for movement of 
cholesterol in the cultured cell. Other techniques 
would be required to demonstrate the operation of 
these pathways in an intact animal. 
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